HCSG vs BGSF

For growth investors, Healthcare Services Group, Inc.

(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -65. 8% for BGSF, Inc. (BGSF). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 26. 8x trailing P/E (20. 3x forward), making it the more compelling value choice. Analysts rate Healthcare Services Group, Inc. (HCSG) a "Hold" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Healthcare Services Group, Inc.

(HCSG) delivered a total return of -21. 8%, compared to -34. 4% for BGSF, Inc. (BGSF). Over 10 years, the gap is even starker: BGSF returned -11. 9% versus HCSG's -28. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), BGSF, Inc.

(BGSF) is the lower-risk stock at 0. 95β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 18% more volatile than BGSF relative to the S&P 500. On balance sheet safety, BGSF, Inc. (BGSF) carries a lower debt/equity ratio of 3% versus 5% for Healthcare Services Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Healthcare Services Group, Inc.

(HCSG) is pulling ahead at 7. 1% versus -65. 8% for BGSF, Inc. (BGSF). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -212. 9% for BGSF, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Healthcare Services Group, Inc.

(HCSG) is the more profitable company, earning 3. 2% net margin versus -8. 3% for BGSF, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus -10. 0% for BGSF. At the gross margin level — before operating expenses — BGSF leads at 34. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, BGSF (37.

2% yield) pays a dividend. HCSG does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, BGSF, Inc.

(BGSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95), 37. 2% yield). Both have compounded well over 10 years (BGSF: -11. 9%, HCSG: -28. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HCSG (Healthcare) and BGSF (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HCSG is a small-cap quality compounder stock; BGSF is a small-cap income-oriented stock. BGSF pays a dividend while HCSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.